Galmed Pharmaceuticals
GLMD
#11043
Rank
ยฃ3.77 M
Marketcap
ยฃ3.53
Share price
21.05%
Change (1 day)
390.85%
Change (1 year)

Earnings for Galmed Pharmaceuticals (GLMD)

Earnings in 2026 (TTM): -ยฃ8.49 Million

According to Galmed Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ7.87 Million a decrease over its 2024 earnings that were of -ยฃ5.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galmed Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ8.49 Million7.84%
2025 -ยฃ7.87 Million37.14%
2024 -ยฃ5.74 Million8.75%
2023 -ยฃ5.28 Million-61.31%
2022 -ยฃ13.64 Million-44.97%
2021 -ยฃ24.78 Million12.85%
2020 -ยฃ21.96 Million40.61%
2019 -ยฃ15.62 Million109.19%
2018 -ยฃ7.47 Million-20.47%
2017 -ยฃ9.39 Million-27%
2016 -ยฃ12.86 Million58.6%
2015 -ยฃ8.11 Million16.7%
2014 -ยฃ6.95 Million-47.94%
2013 -ยฃ13.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Evoke Pharma
EVOK
-ยฃ3.61 Million-58.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-ยฃ1.83 Billion 20,987.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-ยฃ17.74 Million 104.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-ยฃ69.43 Million 702.26%๐Ÿ‡บ๐Ÿ‡ธ USA